- Acute pain management
- Amyotrophic Lateral Sclerosis (ALS)
- Chronic pain
- Huntington’s Disease
- Inflammatory bowel disease
- Parkinson’s Disease
- Post-Traumatic Stress Disorder
- Multiple Sclerosis
- Opioid substitution
- Spinal cord damage
PATIENT POSSESSION LIMITS
As initially implemented, the law permits qualified patients to possess a 30 day supply of cannabis-infused, non-smokable products. but only non-smokable preparations allowed. Regulations announced by the Department of Health in 2017 state, “[R]egistered organizations will be allowed to manufacture and distribute additional products including topicals such as lotions, ointments and patches, as well as solid and semi-solid products including chewable and effervescent tablets and lozenges. Certain non-smokable forms of ground plant material will also be permissible for manufacture and distribution.” Legislation signed into law in 2021 amended these rules to permit qualified patients to possess a 60-day supply of cannabis and removed the prior prohibitions on smoking.
Yes, as initially enacted, five producers of cannabis-based preparations and up to 20 dispensing centers were to be licensed by the state. In 2017, the Department of Health registered five additional entities to manufacture and dispense cannabis-infused products.
STATE-LICENSED DISPENSARIES OPERATIONAL
Yes, each certified patient may have up to two caregivers, and each caregiver may serve no more than five certified patients.
ESTIMATED NUMBER OF REGISTERED PATIENTS
- Source: New York State Department of Health, as of April 2021